These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9115500)

  • 1. Role of axillary dissection in mammographically detected breast cancer.
    Jamali FR; Kurtzman SH; Deckers PJ
    Surg Oncol Clin N Am; 1997 Apr; 6(2):343-58. PubMed ID: 9115500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary dissection: when and how radical?
    Morrow M
    Semin Surg Oncol; 1996; 12(5):321-7. PubMed ID: 8873319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is axillary dissection always indicated in invasive breast cancer?
    Chadha M; Axelrod D
    Oncology (Williston Park); 1997 Oct; 11(10):1463-8; discussion 1468, 1473-9. PubMed ID: 9348554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic adjuvant therapy in mammographically discovered invasive cancer.
    Wood WC
    Surg Oncol Clin N Am; 1997 Apr; 6(2):381-4. PubMed ID: 9115502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
    Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
    Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
    Heimann R; Munsell M; McBride R
    Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast cancer: axillary dissection--or an unnecessary procedure?].
    Schäfer P
    Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
    Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
    Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of axillary disease.
    Caudle AS; Cupp JA; Kuerer HM
    Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic benefits evaluated: new guidelines for systemic adjuvant therapy for axillary node-negative breast cancer vs. implementation of sentinel node biopsy procedure].
    Roumen RM
    Ned Tijdschr Geneeskd; 2000 May; 144(21):980-4. PubMed ID: 10858787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of axillary dissection in mammographically detected carcinoma.
    Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
    J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node dissection: does it have a role in primary breast cancer?
    Pack MS; Thomas RS
    Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma.
    Jackson JS; Olivotto IA; Wai M D E; Grau C; Mates D; Ragaz J
    Cancer; 2000 Apr; 88(8):1852-62. PubMed ID: 10760762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer.
    Ollila DW; Brennan MB; Giuliano AE
    Arch Surg; 1998 Jun; 133(6):647-51. PubMed ID: 9637465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.
    Kuznetsova M; Graybill JC; Zusag TW; Hartsell WF; Griem KL
    Radiology; 1995 Nov; 197(2):507-10. PubMed ID: 7480703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.